Coronavirus Live Count Map India
remove_red_eye 543 Views
Plasma therapy can check hypoxia in Covid patients: Study
KOLKATA: The Centre of Scientific & Industrial Research (CSIR) and Bengal government’s randomized control trial on use of convalescent plasma therapy in severe Covid-19 patients has shown an immediate reduction in hypoxia (oxygen deprivation) as compared to patients on standard therapy. The findings also indicate an anti-inflammatory role of the therapy. The study is, however, different in scope from the one conducted recently by the Indian Council of Medical Research (ICMR), which suggested that plasma therapy does not have an effective role in either preventing the progression of the disease or in reducing mortality. While the ICMR study examined the efficacy of plasma therapy, the one by CSIR and Bengal goes into the immunological impact. It is the first such scientific study in India. ....read more
Understanding White Clot vs Red Clot in COVID-19
Red vs white thrombi. Treating the right clot is crucial. Join us today at 7:00 PM on MEDtalks with Dr K K Aggarwal for an in depth discussion on "Understanding White Clot vs Red Clot in COVID-19."Join us today at 7 pm on Medtalks with Dr K K Aggarwal as he discusses about bringing out your hidden talent with Ms. Kaveta Chaudhry, well known for her portrayal of a focused police officer in the pathbreaking series Udaan. Just click on www.facebook.com/drkkaggarwal or https://perfecthealthmela.com/vevent/general-webinar.php
CMAAO Coronavirus Facts and Myth Buster: 2nd COVID-19 infection more severe
With input from Dr Monica Vasudev 1091:Second COVID-19 infection more severe than first infection in 4 Mumbai health workers[EXCERPTS FROM TOI STORY BY MALATHY IYER]1.COVID-19 reinfection has been confirmed using whole genome sequencing in four healthcare workers from Mumbai.2.All of them have a more severe infection as compared to the earlier episode, reports a preprint published on The Lancet medical journal’s website. ....read more
World COVID Meter 24th September: Acute manageable immunogenic thrombogenic inflammatory viral disease pandemic
Cases: 1M April 2, 2M April 15, 3M April 27, 4M May 8, 5M May 20, 6M May 30, 7M June 7, 8M June 15, 9M June 22, 10M June 29th, 11M July 4, 12M July 8, 13M July 13, 14M July 17, 15M July 23, 16M July 25, 17M July 29, 18M August 1, 19M August 6, 20M August 10, 21M August 16, 22M August 19, 23M August 21, 24M August 27, 25M August 30, 26M September 3, 27M September 7, 28M September 10, 29M September 14, 30M September 18, 31M September 21 Ground Zero: Wuhan - in live animal market or cafeteria for animal pathogens: 10th January; Total cases are based on RT PCR, 67% sensitivity Coronavirus Cases: 32,090,798,Deaths: 981,927,Recovered: 23,674,178,ACTIVE CASES 7,434,693 ....read more
Spiritual prescriptions learnt from patients
As doctors we are witness to human suffering. When we were young in medical college, we were quite disturbed seeing the sufferings of the people. But, in our practice, we have learnt many spiritual prescriptions from our patients. These have not only helped us heal our patients but also changed our perception to health and sickness. I recall Swami Bodhanand, a disciple of Swami Chinmayananda, was once hospitalized under our care. When I asked him to give me a spiritual message, he said only two words "Detached Attachment". He said, "As a doctor you should behave like a lotus leaf. It is wet as long as there is a drop of water on it, but once the drop is out, the leaf is as dry as if the water was never there." The message was that "we should be attached to our patients as long as they are with us. The day they die, we should be completely detached from them or else we will not be able to treat other patients". ....read more
Video of The day
Healthcare News Monitor
Pharma to beat COVID-19 blues: Higher exports to help sector eke out 8-9% growth this fiscal
While the coronavirus pandemic has ravaged Indian economy along with several sectors, the domestic pharmaceutical industry is expected to beat the COVID-19 blues on account of higher exports. “The Rs 2.8 lakh crore Indian pharmaceutical sector is set to emerge more or less unscathed from the Covid-19 pandemic this fiscal. The sector is well-diversified with exports and domestic formulations accounting for almost equal share,” a CRISIL report said on Thursday. The sector is likely to report a 11-12% growth in exports this financial year as against 10% last fiscal and will outpace growth in domestic formulations expected at 5-6%. This will lead to 8-9% overall growth, down just 150 basis points on-year. While companies watched by CRISIL may report a decline in operating profitability, they will still report healthy profit at nearly 19% despite higher input prices. These 350 companies represent 70% of the sector revenue.
THE NEWS SCROLL
New Delhi, Sep 24 (PTI) The US arm of domestic pharma major Sun Pharma has said it is voluntarily recalling one lot of Riomet ER oral suspension in the US market, due to the presence of a probable human carcinogen above the acceptable daily intake limit. Sun Pharmaceutical Industries Inc, a wholly-owned subsidiary of Sun Pharmaceutical Industries, is voluntarily recalling one lot of Riomet ER (metformin hydrochloride for extended-release oral suspension) 500 mg per 5 mL to the consumer level, the company said in an announcement posted on the website of the United States Food and Drug Administration. "The reason for the recall is due to the level of N-Nitrosodimethylamine (NDMA), which has been found to be above the allowable acceptable daily intake (ADI) limit established by the USFDA," it added.
New Delhi: Delhi Deputy Chief Minister Manish Sisodia, who has been diagnosed with dengue and COVID-19, is shifted to Max Hospital, Saket, from Lok Nayak Jai Prakash Narayan (LNJP) hospital here on Thursday (September 25). Sisodia was earlier admitted to LNJP hospital after he complained of fever and low oxygen levels. He has also been tested positive for the novel coronavirus, Office of Delhi Deputy CM said. Earlier on September 14, the Deputy Chief Minister had informed about his positive test results for COVID-19, following which he had isolated himself. Sisodia was admitted to Lok Nayak Jai Prakash Narayan (LNJP) Hospital on Wednesday from being under home-isolation after he had contracted the infection.
New Delhi, Sep 24: There is “no standard protocol” for treatment of patients who have contracted a double infection of COVID-19 and dengue, and a very “finely balanced” approach is needed to tackle both the ailments at once, experts said on Thursday. Delhi Deputy Chief Minister Manish Sisodia who was shifted to LNJP Hospital on Wednesday for COVID-19 treatment, has now tested positive for dengue, perhaps the first prominent personality in the city to have been diagnosed with both infections. Medical Director of Rajiv Gandhi Super Speciality Hospital (RGSSH) Dr B L Sherwal said, both the diseases have no specific treatment, which makes it even difficult for treating doctors of such patients. “Both COVID-19 and dengue need symptomatic treatment and in some aspects the treatment is kind of contradictory and this tricky. In COVID-19, we inject heparin drug subcutaneously which ultimately reaches the blood stream, and this is done to prevent embolism in these patients which can prove fatal,” he told PTI.